These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15888251)

  • 21. Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia.
    Patsouris E; Korkolopoulou P; Androulaki A; Douzinas E; Kosmopoulou O; Kordossis T
    Pathology; 2003 Aug; 35(4):330-5. PubMed ID: 12959769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes.
    Ribatti D; Polimeno G; Vacca A; Marzullo A; Crivellato E; Nico B; Lucarelli G; Dammacco F
    Leukemia; 2002 Sep; 16(9):1680-4. PubMed ID: 12200681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations.
    Lekovic D; Gotic M; Skoda R; Beleslin-Cokic B; Milic N; Mitrovic-Ajtic O; Nienhold R; Sefer D; Suboticki T; Buac M; Markovic D; Diklic M; Cokic VP
    Ann Hematol; 2017 Mar; 96(3):393-404. PubMed ID: 27924369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia.
    Zhelyazkova AG; Tonchev AB; Kolova P; Ivanova L; Gercheva L
    Scand J Clin Lab Invest; 2008; 68(6):492-500. PubMed ID: 18609087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum TNF-alpha concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes.
    Alexandrakis M; Coulocheri S; Xylouri I; Ganotakis E; Eliakis P; Karkavitsas N; Eliopoulos GD
    Haematologia (Budap); 1998; 29(1):13-24. PubMed ID: 9704253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.
    Verstovsek S; Kantarjian H; Estey E; Aguayo A; Giles FJ; Manshouri T; Koller C; Estrov Z; Freireich E; Keating M; Albitar M
    Leukemia; 2001 Aug; 15(8):1165-70. PubMed ID: 11480557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic evaluation of the microvascular network in myelodysplastic syndromes.
    Korkolopoulou P; Apostolidou E; Pavlopoulos PM; Kavantzas N; Vyniou N; Thymara I; Terpos E; Patsouris E; Yataganas X; Davaris P
    Leukemia; 2001 Sep; 15(9):1369-76. PubMed ID: 11516097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors.
    Negaard HF; Iversen N; Bowitz-Lothe IM; Sandset PM; Steinsvik B; Ostenstad B; Iversen PO
    Leukemia; 2009 Jan; 23(1):162-9. PubMed ID: 18800145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum level of angiogenesis-related cytokins in patients with myelodysplastic syndrome].
    Zhao MQ; Zhao HG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):519-22. PubMed ID: 17605857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [[The role of TNF-alpha in myelodysplastic syndrome: immunoserologic and immunohistochemical studies] ].
    Molnár L; Berki T; Hussain A; Németh P; Losonczy H
    Orv Hetil; 2000 Aug; 141(33):1807-11. PubMed ID: 10979309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant.
    Sucak GT; Aki SZ; Yüzbaşioğlu B; Akyürek N; Yağci M; Bağriaçik U; Haznedar R
    Leuk Lymphoma; 2011 Jul; 52(7):1281-9. PubMed ID: 21599578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes.
    Cortelezzi A; Fracchiolla NS; Mazzeo LM; Silvestris I; Pomati M; Somalvico F; Bertolini F; Mancuso P; Pruneri GC; Gianelli U; Pasquini MC; Cortiana M; Deliliers GL
    Leuk Lymphoma; 2005 Sep; 46(9):1345-51. PubMed ID: 16109613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of FLT3-ligand in the angiogenic process of multiple myeloma.
    Kokonozaki M; Tsirakis G; Devetzoglou M; Kyriakaki S; Antonakis A; Vyzoukaki R; Pappa CA; Tzardi M; Alexandrakis MG
    Leuk Res; 2015 Dec; 39(12):1467-72. PubMed ID: 26521986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis in multiple myeloma.
    Jakob C; Sterz J; Zavrski I; Heider U; Kleeberg L; Fleissner C; Kaiser M; Sezer O
    Eur J Cancer; 2006 Jul; 42(11):1581-90. PubMed ID: 16797965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis.
    Passam FH; Alexandrakis MG; Moschandrea J; Sfiridaki A; Roussou PA; Siafakas NM
    Int J Immunopathol Pharmacol; 2006; 19(1):161-70. PubMed ID: 16569354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.
    Zhang Z; Li X; Guo J; Xu F; He Q; Zhao Y; Yang Y; Gu S; Zhang Y; Wu L; Chang C
    Eur J Haematol; 2013 May; 90(5):375-84. PubMed ID: 23331180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.